Health Trials

Clinical trials

3

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Safety and Effectiveness Study of SQ-Kyrin System for Functional Mitral Regurgitation in EU

The investigation objective of this study is to evaluate the safety and effectiveness of the Transcatheter Mitral Valve Clip Delivery System and Steerable Guide Catheter in the population of FMR patients and the accessories devices when used in conjunction with the Transcatheter Mitral Valve Clip Delivery System and Steerable Guide Catheter.

Participants needed: 34
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Shanghai Shenqi Medical Technology Co., LtdUpdated: Feb 12, 2025Locations: 1
Eligibility criteria

Participant who has provided written informed consent for the investigation. [+14]

Life expectancy <1 year due to non-cardiac conditions or heart failure deemed su... [+27]

Read more
Status: Not yet recruiting

Efficacy and Safety of Intraparenchymal Portal Vein Covered Stents in Treating Portal Hypertension and Its Complications

The objective of this study is to assess the non-inferiority of the intraparenchymal portal vein covered stent in terms of safety and efficacy for managing portal hypertension and its related complications, in comparison to the currently available TIPS Covered Stent System by GORE.

Participants needed: 258
Trial details
Age: 18-75Biological sex: AllType: InterventionalSponsor: Shanghai Shenqi Medical Technology Co., LtdUpdated: Mar 20, 2024Locations: 1
Eligibility criteria

Age 18-75 years (inclusive); male or non-pregnant female. [+2]

Severe right heart failure, congestive heart failure (LVEF < 40%), or severe val... [+15]

Read more
Status: Recruiting

SQ-Kyrin TMVr FIM Study

A feasibility study to evaluate the effectiveness and safety of the SQ-Kyrin Transcatheter Edge-to-Edge Valve Repair System for the treatment of moderate-to-severe mitral regurgitation in patients with high surgical risk.

Participants needed: 20
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Shanghai Shenqi Medical Technology Co., LtdUpdated: Sep 10, 2021Locations: 1
Eligibility criteria

Severe mitral valve regurgitation ≥ 3+ (moderate-to-severe mitral regurgitation... [+13]

History of cardiac and mitral valve surgeries; [+23]

Read more